Viveve Medical Stock Net Income
| VIVE Stock | USD 0.0002 0.0001 33.33% |
As of the 28th of February, Viveve Medical has the Risk Adjusted Performance of 0.1029, coefficient of variation of 823.05, and Variance of 10091.38. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viveve Medical, as well as the relationship between them. Please validate Viveve Medical risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Viveve Medical is priced more or less accurately, providing market reflects its prevalent price of 2.0E-4 per share. As Viveve Medical appears to be a penny stock we also recommend to double-check its jensen alpha numbers.
Viveve Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Viveve Medical's valuation are provided below:Viveve Medical does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Viveve |
Viveve Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Viveve Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Viveve Medical.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in Viveve Medical on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Viveve Medical or generate 0.0% return on investment in Viveve Medical over 90 days. Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for t... More
Viveve Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Viveve Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Viveve Medical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1206 | |||
| Maximum Drawdown | 877.78 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 50.0 |
Viveve Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viveve Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Viveve Medical's standard deviation. In reality, there are many statistical measures that can use Viveve Medical historical prices to predict the future Viveve Medical's volatility.| Risk Adjusted Performance | 0.1029 | |||
| Jensen Alpha | 11.69 | |||
| Total Risk Alpha | 1.71 | |||
| Treynor Ratio | 1.93 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Viveve Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Viveve Medical February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1029 | |||
| Market Risk Adjusted Performance | 1.94 | |||
| Mean Deviation | 28.82 | |||
| Coefficient Of Variation | 823.05 | |||
| Standard Deviation | 100.46 | |||
| Variance | 10091.38 | |||
| Information Ratio | 0.1206 | |||
| Jensen Alpha | 11.69 | |||
| Total Risk Alpha | 1.71 | |||
| Treynor Ratio | 1.93 | |||
| Maximum Drawdown | 877.78 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 50.0 | |||
| Skewness | 7.64 | |||
| Kurtosis | 60.7 |
Viveve Medical Backtested Returns
Viveve Medical is out of control given 3 months investment horizon. Viveve Medical owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.17, which indicates the firm had a 0.17 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty different technical indicators, which can help you to evaluate if expected returns of 27.96% are justified by taking the suggested risk. Use Viveve Medical Coefficient Of Variation of 823.05, risk adjusted performance of 0.1029, and Variance of 10091.38 to evaluate company specific risk that cannot be diversified away. Viveve Medical holds a performance score of 13 on a scale of zero to a hundred. The entity has a beta of 6.33, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Viveve Medical will likely underperform. Use Viveve Medical variance, as well as the relationship between the potential upside and day typical price , to analyze future returns on Viveve Medical.
Auto-correlation | -0.07 |
Very weak reverse predictability
Viveve Medical has very weak reverse predictability. Overlapping area represents the amount of predictability between Viveve Medical time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Viveve Medical price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Viveve Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | 0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Viveve Medical reported net income of (22.03 Million). This is 106.45% lower than that of the Health Care Equipment & Supplies sector and 109.25% lower than that of the Health Care industry. The net income for all United States stocks is 103.86% higher than that of the company.
Viveve Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Viveve Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Viveve Medical could also be used in its relative valuation, which is a method of valuing Viveve Medical by comparing valuation metrics of similar companies.Viveve Medical is currently under evaluation in net income category among its peers.
Viveve Fundamentals
| Return On Equity | -2.11 | |||
| Return On Asset | -0.62 | |||
| Operating Margin | (3.10) % | |||
| Current Valuation | 4.26 M | |||
| Shares Outstanding | 10.72 M | |||
| Shares Owned By Institutions | 5.21 % | |||
| Number Of Shares Shorted | 374.24 K | |||
| Price To Earning | (2.59) X | |||
| Price To Book | 3.62 X | |||
| Price To Sales | 0.66 X | |||
| Revenue | 6.43 M | |||
| Gross Profit | 620 K | |||
| EBITDA | (19.89 M) | |||
| Net Income | (22.03 M) | |||
| Cash And Equivalents | 9.43 M | |||
| Cash Per Share | 0.88 X | |||
| Total Debt | 5.12 M | |||
| Debt To Equity | 1.12 % | |||
| Current Ratio | 1.32 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (12.88 M) | |||
| Short Ratio | 4.15 X | |||
| Earnings Per Share | (2.55) X | |||
| Price To Earnings To Growth | (0.13) X | |||
| Target Price | 3.1 | |||
| Number Of Employees | 47 | |||
| Beta | 0.37 | |||
| Market Capitalization | 1.08 M | |||
| Total Asset | 25.91 M | |||
| Retained Earnings | (68.62 M) | |||
| Working Capital | 13.21 M | |||
| Current Asset | 18.53 M | |||
| Current Liabilities | 5.32 M | |||
| Z Score | -2.8 | |||
| Net Asset | 25.91 M |
About Viveve Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Viveve Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viveve Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viveve Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Viveve Pink Sheet
Viveve Medical financial ratios help investors to determine whether Viveve Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viveve with respect to the benefits of owning Viveve Medical security.